Bone marrow changes in intensive care patients
Part of Infections clinical trials.
This study looks at how the bone marrow behaves in people with sepsis and other critical illnesses. It aims to see if changes in bone marrow are linked to how sick a patient is and their chance of recovery. Participants will have a small sample of bone marrow taken from the pelvis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- If you are a patient, you must be in the intensive care unit (ICU) and have been there for about 1-3 days.
- This trial is for people with sepsis (a severe infection), people with other serious illnesses (like major trauma or after major surgery), and healthy adults for comparison.
- You must not have certain blood diseases, active cancer, or a weakened immune system (from drugs, transplant, or HIV).
- You must not have had a blood transfusion in the past 3 months.
- You must be able to give consent or have someone who can give consent for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at abnormal immune cells (from the bone marrow) in people with sepsis or severe trauma with shock. It aims to understand why the body’s immune response gets out of balance, which could help guide future treatments.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
This study looks at how sepsis (a severe infection) affects the immune system. The goal is to see if certain blood markers can help doctors predict recovery, which could improve the care of future patients with septic shock.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.